Continue to site >
Trending ETFs
You have successfully subscribed to Advisor Access. Thank you!
Help us personalize your experience.
Which type of investor describes you best?
Help us personalize your experience.
What is your AUM?
Knowing your investable assets will help us build and prioritize features that will suit your investment needs.

Congratulations on personalizing your experience.

Email is verified. Thank you!

Name

As of 08/31/2021

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Biotechnology Opportunities Portfolio, Series 2020-2

BIOABX | Fund

$12.24

-

0.00%

0.40%

Vitals

YTD Return

5.9%

1 yr return

N/A

3 Yr Avg Return

N/A

5 Yr Avg Return

N/A

Net Assets

$N/A

Holdings in Top 10

52.7%

52 WEEK LOW AND HIGH

$12.2
$9.48
$13.15

Expenses

OPERATING FEES

Expense Ratio 0.40%

SALES FEES

Front Load 0.00%

Deferred Load 2.25%

TRADING FEES

Turnover N/A

Redemption Fee N/A

Min Investment

Standard (Taxable)

$1,000

IRA

N/A

Fund Classification

Fund Type

Unknown

Name

As of 08/31/2021

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Biotechnology Opportunities Portfolio, Series 2020-2

BIOABX | Fund

$12.24

-

0.00%

0.40%

BIOABX - Profile

Distributions

  • YTD Total Return 5.9%
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio N/A
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Semi-Annually

Fund Details

  • Legal Name
    Biotechnology Opportunities Portfolio, Series 2020-2
  • Fund Family Name
    Advisors Asset Management, Inc.
  • Inception Date
    Oct 06, 2020
  • Shares Outstanding
    N/A
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States

Fund Description

BIOABX - Performance

Return Ranking - Trailing

Period BIOABX Return Category Return Low Category Return High Rank in Category (%)
YTD 5.9% -25.6% 23.4% 3.35%
1 Yr N/A -30.0% 21.8% N/A
3 Yr N/A* -18.7% 19.7% N/A
5 Yr N/A* -14.7% 15.3% N/A
10 Yr N/A* -6.2% 15.7% N/A

* Annualized

Return Ranking - Calendar

Period BIOABX Return Category Return Low Category Return High Rank in Category (%)
2023 N/A -53.9% 11.7% N/A
2022 N/A -22.3% 18.5% N/A
2021 N/A -4.7% 41.4% N/A
2020 N/A -10.2% 13.1% N/A
2019 N/A -5.7% 26.9% N/A

Total Return Ranking - Trailing

Period BIOABX Return Category Return Low Category Return High Rank in Category (%)
YTD 5.9% -41.2% 23.4% 3.35%
1 Yr 15.7% -30.0% 28.3% 5.08%
3 Yr N/A* -18.7% 19.7% N/A
5 Yr N/A* -14.7% 15.3% N/A
10 Yr N/A* -6.2% 15.7% N/A

* Annualized

Total Return Ranking - Calendar

Period BIOABX Return Category Return Low Category Return High Rank in Category (%)
2023 N/A -53.9% 11.7% N/A
2022 N/A -22.3% 18.5% N/A
2021 N/A -4.7% 41.4% N/A
2020 N/A -10.2% 13.1% N/A
2019 N/A -5.7% 26.9% N/A

NAV & Total Return History

BIOABX - Holdings

Concentration Analysis

BIOABX Category Low Category High BIOABX % Rank
Net Assets N/A 732 K 46.2 B N/A
Number of Holdings 34 21 473 89.01%
Net Assets in Top 10 5.27 K 2.18 K 21.6 B 97.91%
Weighting of Top 10 52.70% 12.3% 80.8% 23.56%

Top 10 Holdings

  1. Moderna Inc 11.53%
  2. BioNTech SE ADR 9.55%
  3. AstraZeneca PLC ADR 4.94%
  4. Fate Therapeutics Inc 4.72%
  5. NovoCure Ltd 4.44%
  6. Biohaven Pharmaceutical Holding Co Ltd 4.29%
  7. Alexion Pharmaceuticals Inc 3.79%
  8. Novavax Inc 3.74%
  9. Natera Inc 3.74%
  10. Halozyme Therapeutics Inc 3.63%

Asset Allocation

Weighting Return Low Return High BIOABX % Rank
Stocks 		100.00% 85.37% 106.13% 8.90%
Preferred Stocks 		0.00% 0.00% 7.86% 29.32%
Other 		0.00% -22.99% 3.38% 37.70%
Convertible Bonds 		0.00% 0.00% 0.37% 28.80%
Cash 		0.00% -0.10% 9.01% 84.82%
Bonds 		0.00% 0.00% 12.39% 27.75%

Stock Sector Breakdown

Weighting Return Low Return High BIOABX % Rank
Healthcare 		100.00% 59.26% 100.00% 17.28%
Utilities 		0.00% 0.00% 0.00% 25.13%
Technology 		0.00% 0.00% 22.69% 31.41%
Real Estate 		0.00% 0.00% 7.13% 29.84%
Industrials 		0.00% 0.00% 7.02% 29.84%
Financial Services 		0.00% 0.00% 1.85% 47.12%
Energy 		0.00% 0.00% 0.00% 25.13%
Communication Services 		0.00% 0.00% 9.11% 28.80%
Consumer Defense 		0.00% 0.00% 25.73% 33.51%
Consumer Cyclical 		0.00% 0.00% 14.20% 29.32%
Basic Materials 		0.00% 0.00% 14.83% 48.17%

Stock Geographic Breakdown

Weighting Return Low Return High BIOABX % Rank
US 		77.75% 53.67% 104.41% 75.92%
Non US 		22.25% 0.00% 45.40% 20.42%

BIOABX - Expenses

Operational Fees

BIOABX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.40% 0.08% 3.13% 85.57%
Management Fee N/A 0.00% 1.25% N/A
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

BIOABX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load 0.00% 0.00% 5.75% 83.78%
Deferred Load 2.25% 1.00% 5.00% 20.59%

Trading Fees

BIOABX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BIOABX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 0.00% 238.00% N/A

BIOABX - Distributions

Dividend Yield Analysis

BIOABX Category Low Category High BIOABX % Rank
Dividend Yield 0.00% 0.00% 2.44% 6.63%

Dividend Distribution Analysis

BIOABX Category Low Category High Category Mod
Dividend Distribution Frequency Semi-Annually Annually Quarterly Annually

Net Income Ratio Analysis

BIOABX Category Low Category High BIOABX % Rank
Net Income Ratio N/A -2.54% 1.92% N/A

Capital Gain Distribution Analysis

BIOABX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Distributions History

View More +

BIOABX - Fund Manager Analysis

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.26 2.12

Advertisement

×

Wait! Do you know all the important aspects of mutual funds?

×

Free Advisor Access newsletter emailed to you.

Receive free and exclusive email updates for financial advisors about best performers, news, CE accredited webcasts and more.

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Disclaimer: By registering, you agree to share your data with MutualFunds.com and opt-in to receiving occasional communications about projects and events. The contents of this form are subject to the MutualFunds.com Privacy Policy. You can unsubscribe at any time.